What Jefferies’ Revised Outlook Means for Lockheed Martin Corporation (LMT) Stock

We recently compiled a list of the 8 Most Oversold Large Cap Stocks to Buy. Lockheed Martin Corporation (NYSE:LMT) is one of the most oversold stocks on this list.

TheFly reported on April 26 that LMT saw its valuation outlook revised as Jefferies reduced its price target to $595 from $640 while maintaining a Hold rating on the stock. The firm noted that the company’s first quarter performance was in line with expectations, describing results as broadly as anticipated.

Separately, in recent news, on May 8, Lockheed Martin Corporation (NYSE:LMT) received a $407.16 million contract modification under the Aegis Ballistic Missile Defense Weapon Systems program, awarded through the Missile Defense Agency. The modification continues ongoing engineering, development, and certification work focused on integrating advanced air and missile defense capabilities into the Aegis BMD system, including applications for the Aegis Guam configuration.

What Jefferies’ Revised Outlook Means for Lockheed Martin Corporation (LMT) Stock

The effort will be carried out in Moorestown, New Jersey, and Guam, with performance extending through December 2029. Initial funding includes allocations from fiscal 2026 research, development, testing, evaluation, and procurement budgets. The adjustment increases the overall contract value from approximately $1.53 billion to $1.94 billion, reflecting expanded scope and continued investment in missile defense system enhancement and deployment capabilities.

Lockheed Martin Corporation (NYSE:LMT) is a global aerospace and defense company based in Bethesda. It develops advanced defense systems and aircraft, including the F-35 Lightning II.

While we acknowledge the risk and potential of LMT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than LMT and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Cancer Stocks to Buy for the Long Term and 10 Most Popular Stocks on Robinhood in 2026.

Disclosure: None. Follow Insider Monkey on Google News.